Cue Biopharma is trading at $32.00 (+5.79%) in early session action, rebounding from a weak July 28 close.
- The move follows a volatile stretch and appears tied to short-term trading momentum rather than a fresh company-specific announcement.
- No catalyst is evident in recent news, while the broader biotech sector remains under pressure due to risk-off sentiment and Fed-day caution.